UAB Biomedical FT-ICR MS Laboratory, MCLM 570, 1530 3rd Avenue South, Birmingham, AL 35294, USA.
J Proteome Res. 2012 Feb 3;11(2):692-702. doi: 10.1021/pr200608q. Epub 2011 Dec 29.
IgA is the most abundantly produced antibody and plays an important role in the mucosal immune system. Human IgA is represented by two isotypes, IgA1 and IgA2. The major structural difference between these two subclasses is the presence of nine potential sites of O-glycosylation in the hinge region between the first and second constant region domains of the heavy chain. Thr(225), Thr(228), Ser(230), Ser(232) and Thr(236) have been identified as the predominant sites of O-glycan attachment. The range and distribution of O-glycan chains at each site within the context of adjacent sites in this clustered region create a complex heterogeneity of surface epitopes that is incompletely defined. We previously described the analysis of IgA1 O-glycan heterogeneity by use of high resolution LC-MS and electron capture dissociation tandem MS to unambiguously localize all amino acid attachment sites in IgA1 (Ale) myeloma protein. Here, we report the identification and elucidation of IgA1 O-glycopeptide structural isomers that occur based on amino acid position of the attached glycans (positional isomers) and the structure of the O-glycan chains at individual sites (glycan isomers). These isomers are present in a model IgA1 (Mce1) myeloma protein and occur naturally in normal human serum IgA1. Variable O-glycan chains attached to Ser(230), Thr(233) or Thr(236) produce the predominant positional isomers, including O-glycans composed of a single GalNAc residue. These findings represent the first definitive identification of structural isomeric IgA1 O-glycoforms, define the single-site heterogeneity for all O-glycan sites in a single sample, and have implications for defining epitopes based on clustered O-glycan variability.
IgA 是最丰富产生的抗体,在黏膜免疫系统中发挥重要作用。人类 IgA 由两种同种型组成,IgA1 和 IgA2。这两个亚类之间的主要结构差异在于重链第一和第二恒定区结构域之间铰链区存在九个潜在的 O-糖基化位点。Thr(225)、Thr(228)、Ser(230)、Ser(232)和 Thr(236)已被确定为 O-聚糖附着的主要位点。在该簇区域内的相邻位点的背景下,每个位点的 O-聚糖链的范围和分布会产生复杂的表面表位异质性,这种异质性尚未完全定义。我们之前描述了使用高分辨率 LC-MS 和电子俘获解离串联 MS 分析 IgA1 O-聚糖异质性,以明确确定 IgA1(Ale)骨髓瘤蛋白中所有氨基酸附着位点。在这里,我们报告了 IgA1 O-糖肽结构异构体的鉴定和阐明,这些异构体是基于附着糖的氨基酸位置(位置异构体)和各个位点的 O-聚糖链结构(聚糖异构体)产生的。这些异构体存在于模型 IgA1(Mce1)骨髓瘤蛋白中,并且自然存在于正常人血清 IgA1 中。可变 O-聚糖链附着在 Ser(230)、Thr(233)或 Thr(236)上会产生主要的位置异构体,包括由单个 GalNAc 残基组成的 O-聚糖。这些发现代表了首次明确鉴定结构异构 IgA1 O-糖型,定义了单个样品中所有 O-聚糖位点的单一位点异质性,并对基于聚类 O-聚糖变异性定义表位具有重要意义。